ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619003 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619003; 2) Community: the network communities that were significantly associated with the response to NSC 619003; 3) Molecule: the relationships between components within communities and NSC 619003; 4) MDR: the compounds that were significantly associated with the NSC 619003.

NSC Compound Enrichment Correlation
NSC 610458 Camptothecin Derivative 0.00479683626511385 0.75403683
NSC 639174 Camptothecin Derivative 0.00479683626511392 0.6170426
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.00479683626511392 0.7281847
NSC 664885 Null 0.00479683626511392 0.43048173
NSC 667903 Null 0.00479683626511392 0.49039695
NSC 676395 Cyclobutanemethanol, 1-[[(2-amino-4-chloro-5-[(4-chlorophenyl)azo]- 6-pyrimidinyl)amino]methyl]-3-(3-phenylmethoxy)- 0.00479683626511392 0.28195909
NSC 705437 Null 0.00479683626511392 0.70568588
NSC 742410 5- fluoro-2'-deoxyuridyly-(3'->5')-3'-C-ethynylcytosine 0.00479683626511392 0.60517598
NSC 755423 Null 0.00479683626511392 0.68946139
NSC 105132 Deoxycamptothecin 0.0048681766467277 0.73882972
Total:107  Current:19    [First] [Prev] [Next] [Last]